Learn More
Echelon Biosciences Research Labs AKT INHIBITOR (KP372-1) 5 mg

Supplier: Echelon Biosciences Research Labs B01025MG
KP372-1 directly inhibits the kinase activities of Akt, PDK1 and Flt3 (Fms-like tyrosine kinase 3), which are aberrantly activated in acute myelogenous leukemia (AML). It is a cell permeant inhibitor that decreases the colony-forming ability of AML cells (IC50 < 200 nM) with minimal cytoxic effects on normal hematopoietic progenitor cells. KP372-1 has also been shown to suppress cell proliferation and induce apoptosis in thyroid cancer cells and gliobastoma. Provided as a 1:1 mixture of regioisomers.nn
nn
Solubility
nWater: insoluble, DMSO: 5 mg/mLnStorage
n2-8oC. Stock solutions should be stored frozen (-20oC).nReferences
n1) M. This item is non returnableBy clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.